Who owns ZIOPHARM Oncology?

Key details on ZIOPHARM Oncology (Ticker: ZIOP)

Who owns ZIOPHARM Oncology?

Is ZIOP a good stock to own? Find out who bought ZIOPHARM Oncology, who sold ZIOPHARM Oncology (ZIOP) stock, and who holds a large position in ZIOPHARM Oncology.

Fund Name Number of Shares Share Valuation As Of
Third Security 19.27M $207.56M March 31, 2015
MSDC Management 4.12M $20.89M Dec. 31, 2014
STATE STREET CORPORATION 3.34M $16.96M Dec. 31, 2014
FMR 3.13M $8.28M Sept. 30, 2014
Vanguard 2.72M $13.80M Dec. 31, 2014
Essex Woodlands Health Ventures 2.70M $13.69M Dec. 31, 2014
BlackRock Fund Advisors 2.27M $11.53M Dec. 31, 2014
Belmont Global Advisors 2.27M $10.40M March 31, 2014
SUSQUEHANNA INTERNATIONAL 1.84M $4.86M Sept. 30, 2014
Jennison Associates 1.52M $4.01M Sept. 30, 2014
MORGAN STANLEY 1.32M $6.71M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 1.21M $6.16M Dec. 31, 2014
Barclays 1.04M $4.15M March 31, 2014
NORTHERN TRUST 896396 $4.55M Dec. 31, 2014
S.A.C. Capital Advisors 888000 $1.86M June 30, 2013
Visium Asset Management 827500 $3.44M Dec. 31, 2012
Ayer Capital Management 809009 $4.41M Sept. 30, 2012
Austin W. Marxe and David M. Greenhouse 776741 $3.23M Dec. 31, 2012
Inves 722342 $3.31M March 31, 2014
GROUP ONE TRADING 617836 $2.49M June 30, 2014
Geode Capital Management 577215 $2.93M Dec. 31, 2014
Royce & Associates 576000 $2.28M Sept. 30, 2013
Oxford Asset Management 568669 $3.07M March 31, 2012

Who sold ZIOPHARM Oncology?

Fund Name Date Sold Number of Shares Sold Share Valuation
QVT Financial Sept. 30, 2011 936952 $4.13M
Baker Bros. Advisors Sept. 30, 2011 849500 $3.75M
Sunrise Partners Limited Partnership Dec. 31, 2010 1.21M $5.66M